Cilostazol
- Product NDC
- 50090-5329
- 11-digit product format
- 500905329
- Labeler code
- 50090
- Product ID
- 50090-5329_79255804-ac0f-4f77-98bb-f25230ed84f8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cilostazol
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA077027
- Marketing category
- ANDA
- Marketing start
- 2012-04-24
- Marketing end
- 0000-00-00
- Substance
- CILOSTAZOL
- Active strength
- 50 mg/1
- Pharmacologic classes
- Phosphodiesterase 3 Inhibitor [EPC],Phosphodiesterase 3 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-5329-0 | 50090532900 | 30 TABLET in 1 BOTTLE (50090-5329-0) | 30 tablet | 2020-11-02 | 0000-00-00 | No | No | Current |